SEVENUM, THE NETHERLANDS - September 28, 2026 ( NEWMEDIAWIRE ) - Today, Redcare Pharmacy N.V. announced that it is raising its full-year 2026 guidance for the second time this year.
The upgrade is driven by continued strong momentum in Rx revenue in Germany, which, based on preliminary figures, grew by 51% year-on-year in September and 56% in Q3. September proved to be a strong month despite a high comparison base from the prior year, when the current Rx bonus was introduced. The company will share the full set of figures for the third quarter of 2026 on October 29, 2026.
"Our growth is backed by strong customer satisfaction: eRx NPS continues to rise, up 6 points year-on-year to 80 in August," said Olaf Heinrich, CEO of Redcare Pharmacy.
While Rx revenue in Germany remained strong throughout the quarter, non-Rx revenue in Germany rebounded well in August and September after a softer July. Based on the preliminary figures, the adjusted EBITDA margin remained flat quarter-on-quarter, benefiting from continued operating leverage.
The updated guidance for 2026 is as follows:
Redcare Pharmacy will publish its Interim Statement for the third quarter of 2026 and host its quarterly conference call on October 29, 2026.
Upcoming publications and events.
View the original release on www.newmediawire.com
